This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arromax Pharmatech Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Guobin Liu: Innovator in Pharmaceutical Chemistry
Introduction
Guobin Liu is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds with therapeutic applications. His expertise and dedication to research have led to the development of valuable pharmaceutical compositions.
Latest Patents
Guobin Liu holds a patent for a compound titled "Diphenylaminopyrimidine and triazine compound, and pharmaceutical composition and use thereof." This patent describes a diphenylaminopyrimidine and triazine compound of Formula I, which includes various chemical configurations and properties. The compound exhibits pharmacodynamic and pharmacokinetic properties, along with ALK kinase inhibitory activity, making it a promising candidate for pharmaceutical applications.
Career Highlights
Liu's career is marked by his commitment to advancing pharmaceutical research. He has successfully developed compounds that have the potential to address significant health challenges. His work is characterized by a focus on innovative solutions that can lead to improved therapeutic outcomes.
Collaborations
Guobin Liu collaborates with esteemed colleagues, including Xiaoyong Le and Jian Hong. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.
Conclusion
In summary, Guobin Liu is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important compounds with therapeutic potential. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile